These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1030 related articles for article (PubMed ID: 17030369)

  • 1. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
    Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop.
    Hays SM; Aylward LL; LaKind JS; Bartels MJ; Barton HA; Boogaard PJ; Brunk C; DiZio S; Dourson M; Goldstein DA; Lipscomb J; Kilpatrick ME; Krewski D; Krishnan K; Nordberg M; Okino M; Tan YM; Viau C; Yager JW;
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S4-15. PubMed ID: 18583008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.
    Aylward LL; Kirman CR; Blount BC; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):33-44. PubMed ID: 20685286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context.
    Hays SM; Aylward LL
    J Appl Toxicol; 2009 May; 29(4):275-88. PubMed ID: 19115313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpreting human biomonitoring data in a public health risk context using Biomonitoring Equivalents.
    Hays SM; Aylward LL
    Int J Hyg Environ Health; 2012 Feb; 215(2):145-8. PubMed ID: 22192580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.
    Boogaard PJ; Hays SM; Aylward LL
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):125-32. PubMed ID: 20933039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the communication of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop.
    LaKind JS; Aylward LL; Brunk C; DiZio S; Dourson M; Goldstein DA; Kilpatrick ME; Krewski D; Bartels MJ; Barton HA; Boogaard PJ; Lipscomb J; Krishnan K; Nordberg M; Okino M; Tan YM; Viau C; Yager JW; Hays SM;
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S16-26. PubMed ID: 18579271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of human biomonitoring (HBM) of chemical exposure in the characterisation of health risks under REACH.
    Boogaard PJ; Aylward LL; Hays SM
    Int J Hyg Environ Health; 2012 Feb; 215(2):238-41. PubMed ID: 22177527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomonitoring Equivalents (BE) dossier for trihalomethanes.
    Aylward LL; LaKind JS; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S68-77. PubMed ID: 18579267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foreword: Biomonitoring Equivalents special issue.
    Meek ME; Sonawane B; Becker RA
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S3. PubMed ID: 18395953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomonitoring equivalents for hexachlorobenzene.
    Aylward LL; Hays SM; Gagné M; Nong A; Krishnan K
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):25-32. PubMed ID: 20547196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of Biomonitoring Equivalents for di(2-ethylhexyl)phthalate (CAS No. 117-81-7).
    Aylward LL; Hays SM; Gagné M; Krishnan K
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):249-58. PubMed ID: 19751789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomonitoring Equivalents (BE) dossier for cadmium (Cd) (CAS No. 7440-43-9).
    Hays SM; Nordberg M; Yager JW; Aylward LL
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S49-56. PubMed ID: 18579269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomonitoring Equivalents for benzene.
    Hays SM; Pyatt DW; Kirman CR; Aylward LL
    Regul Toxicol Pharmacol; 2012 Feb; 62(1):62-73. PubMed ID: 22178585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomonitoring Equivalents (BE) dossier for toluene (CAS No. 108-88-3).
    Aylward LL; Barton HA; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S27-36. PubMed ID: 18583006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human milk biomonitoring data: interpretation and risk assessment issues.
    LaKind JS; Brent RL; Dourson ML; Kacew S; Koren G; Sonawane B; Tarzian AJ; Uhl K
    J Toxicol Environ Health A; 2005 Oct; 68(20):1713-69. PubMed ID: 16176917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental chemicals in people: challenges in interpreting biomonitoring information.
    LaKind JS; Barraj L; Tran N; Aylward LL
    J Environ Health; 2008 May; 70(9):61-4. PubMed ID: 18517157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7).
    Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S37-48. PubMed ID: 18579270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation of Biomonitoring Equivalents for di-n-butyl phthalate (DBP), benzylbutyl phthalate (BzBP), and diethyl phthalate (DEP).
    Aylward LL; Hays SM; Gagné M; Krishnan K
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):259-67. PubMed ID: 19751787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomonitoring Equivalents for bisphenol A (BPA).
    Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):18-24. PubMed ID: 20541576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.